FPRX

Five Prime Therapeutics, Inc. News Headlines

$12.12
*  
0.12
1%
Get FPRX Alerts
*Delayed - data as of Oct. 23, 2014 13:40 ET  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FPRX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Five Prime Therapeutics (FPRX) Initiated As a Sell
10/22/2014 9:13:00 AM - TheStreet


Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 6:00:00 PM - Zacks.com


Five Prime: Glaxo Exercises Option for Rights to Muscle-Disease Products
9/16/2014 10:10:00 AM - Dow Jones Business News


Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target
9/15/2014 4:23:00 PM - RTT News


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
8/12/2014 8:51:00 AM - Zacks.com


Bristol-Myers & CytomX Therapeutics Join Forces - Analyst Blog
5/28/2014 11:50:00 AM - Zacks.com


Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
4/23/2014 5:30:01 PM - Zacks.com


Should Five Prime Therapeutics (FPRX) Be On Your Radar Now? - Tale of the Tape
4/10/2014 8:53:01 AM - Zacks.com


Earnings Estimates Moving Higher for Five Prime (FPRX): Time to Buy? - Tale of the Tape
4/4/2014 8:47:01 AM - Zacks.com


Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 11:00:01 AM - Zacks.com


Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 12:00:01 PM - Zacks.com


Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 9:18:01 AM - Zacks.com


Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
10/30/2013 2:47:00 PM - Seeking Alpha


Five Prime Therapeutics - Another Risky Cancer Research Public Offering
9/23/2013 7:05:00 AM - Seeking Alpha


Five Prime Therapeutics prices IPO at $13, within the range
9/17/2013 8:08:06 PM - Renaissance Capital


IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha


12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha


U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha


US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds
9/8/2013 10:23:54 PM - Renaissance Capital


Biotech Five Prime Therapeutics sets terms for $52 million IPO
9/4/2013 5:43:04 PM - Renaissance Capital


U.S. IPO Recap: 11 Deals Prince In Busiest Week Since November 2007, 8 Companies Set Terms
7/30/2013 7:27:00 AM - Seeking Alpha


Biotech Five Prime Therapeutics files for a $60 million IPO
7/28/2013 3:55:32 PM - Renaissance Capital